Skip to main content
. Author manuscript; available in PMC: 2024 May 1.
Published in final edited form as: Med Sci Sports Exerc. 2023 Dec 18;56(5):805–812. doi: 10.1249/MSS.0000000000003365

Table 2. Linear regression adjusted differences between non-arthritic participants and participants with any combination of hip and/or knee arthroplasties in primary activity measures.

Metric Reference Cohort End-Stage Knee and/or Hip Osteoarthritis (n=514) 12+ Months After First Knee or Hip Arthroplasty (n=2,992)
Median Daily Step Count (steps/day) Non-Arthritic (n=68,389) -1,129 [-1,447, -811] (p<0.001) -482 [-619, -345] (p<0.001)
End-Stage Knee and/or Hip Osteoarthritis (n=514) 648 [305, 990] (p<0.001)
Peak Cadence (steps/min) Non-Arthritic (n=68,389) -4.8 [-5.8, -3.9] (p<0.001) -3.3 [-3.7, -2.9] (p<0.001)
End-Stage Knee and/or Hip Osteoarthritis (n=514) 1.6 [0.5, 2.6] (p=0.004)
Overall Acceleration (mg) Non-Arthritic (n=68,389) -0.1 [-0.8, 0.6] (p=0.753) 0.2 [-0.1, 0.5] (p=0.238)
End-Stage Knee and/or Hip Osteoarthritis (n=514) 0.3 [-0.4, 1.0] (p=0.461)
Moderate-to-Vigorous Activity (min/day) Non-Arthritic (n=68,389) -5.8 [-8.7, -3.0] (p<0.001) -2.8 [-4.1, -1.6] (p<0.001)
End-Stage Knee and/or Hip Osteoarthritis (n=514) 3.0 [-0.1, 6.0] (p=0.055)

Estimate [95% confidence interval] in activity metrics adjusted for age, sex, body mass index, season, Charlson comorbidity index, education, ethnicity, alcohol consumption, and smoking status. A negative difference indicates lower activity in the cohort of interest relative to the reference cohort.